Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins.
about
Myc-nick: a cytoplasmic cleavage product of Myc that promotes alpha-tubulin acetylation and cell differentiationEndoplasmic reticulum stress induces p53 cytoplasmic localization and prevents p53-dependent apoptosis by a pathway involving glycogen synthase kinase-3betaDomain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activityThe initial enzyme for glycosylphosphatidylinositol biosynthesis requires PIG-Y, a seventh component.Expression of c-myc is not critical for cell proliferation in established human leukemia linesExpression of Caytaxin protein in Cayman Ataxia mouse models correlates with phenotype severityCloning and functional analysis of a family of nuclear matrix transcription factors (NP/NMP4) that regulate type I collagen expression in osteoblastsc-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activationTruncated forms of the dual function human ASCT2 neutral amino acid transporter/retroviral receptor are translationally initiated at multiple alternative CUG and GUG codonsTransactivation-defective c-MycS retains the ability to regulate proliferation and apoptosisCoordinated regulation of c-Myc and Max in rat liver developmentMYC on the path to cancerMyc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesisMyc-mediated transformation: the repression connection.Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region.c-Myc target genes involved in cell growth, apoptosis, and metabolismc-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cellsThe c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells.Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma.MYC cofactors: molecular switches controlling diverse biological outcomes.Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster.A conserved element in Myc that negatively regulates its proapoptotic activity.Overexpression of c-Myc alters G(1)/S arrest following ionizing radiationBalance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-MycConsistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways.c-Myc promotes differentiation of human epidermal stem cells.High throughput screening identifies modulators of histone deacetylase inhibitorsA role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrestPremetazoan ancestry of the Myc-Max networkHuman MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops.Two independent mechanisms promote expression of an N-terminal truncated USP18 isoform with higher DeISGylation activity in the nucleus.Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune responseExpression of the c-myc proto-oncogene is essential for HIV-1 infection in activated T cells.STAGA recruits Mediator to the MYC oncoprotein to stimulate transcription and cell proliferationDistinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation.Two isoforms of TALDO1 generated by alternative translational initiation show differential nucleocytoplasmic distribution to regulate the global metabolic network.Translational control of eukaryotic gene expression.MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.
P2860
Q24294609-70AED0CC-2794-490F-93CB-DC44D28BC240Q24306430-9B395CB1-3A78-49CA-9800-F215C3AC5D3AQ24307490-5350BB42-0E61-4273-9BDC-52449733D38AQ24323311-8E7ACA50-E39C-4376-B24A-B36BDC5C7B73Q24795800-90FA307F-6225-4781-B067-CE3335B80F50Q27333854-A67972D0-F766-484D-895D-2D83A6D9FA14Q28142178-6D19902A-810B-41AB-A7CA-48C3FD351DA5Q28186628-094F10A7-B142-4B37-98D1-9622F785BC11Q28188660-6EF2C2C4-8A50-4F82-BC6C-D6780BEFA03AQ28292481-4CE56039-8239-43E4-A1C0-4D90F2E2A7ABQ28566937-A7D1795A-CE67-456F-9712-F3C53ED1D629Q29619979-10FCE256-E1D4-4937-B890-C4792DA8CD04Q33612685-F2D992F9-CE08-4F59-BABA-F72BF3B47BF8Q33667285-B2E9DBF9-02F3-4805-B301-D370C13A07BAQ33911776-A9963EED-16DD-4B30-A194-98FB8F4E22F9Q33956988-7C650D35-6A39-48CE-A030-9982205DB671Q33962550-EE14F0AA-E851-4E55-8FEC-F70A5737D7D3Q33963949-3F4E3E4C-8B00-4800-B6C7-BD752C3F08E1Q33964325-6F5E4036-E762-4C35-935F-AB71E22A94E2Q33964663-F54BC3CB-C651-4737-BA70-254AFA11C67DQ34083178-41B02988-511F-44CC-9BAE-9E0E7CE783FAQ34124162-B2F93903-1AC6-41C9-A6B9-245179A2FD94Q34166620-6E914E58-9C0F-43DD-B1E3-E54EA0FFDD48Q34324237-F10D5901-E79F-48CB-9DB7-8E54C5EAC87DQ35082715-65325C20-785C-4365-A52E-C0A108F179A9Q35148175-66A781C7-DD1A-4F64-9AFE-3D2AE3047BA9Q35163974-66D8E57C-1CE8-4597-ABE2-582EA0FDD5F7Q35194892-84BB12ED-1692-4017-82C0-66A1C903B20EQ35195856-100AA642-2525-40C9-BECE-C027B6563154Q35207580-BE091B02-546C-4BBF-A544-757584A33AD7Q35468637-D71F8C78-B6B9-4BD2-8EF3-D4C6791E9AE3Q35641639-3C9765C8-CFD3-4F8C-B737-7DD57CD89E51Q35763085-4A42259C-1936-424C-9150-37A27CB00BE2Q36350110-CDC706B7-6E43-46D9-B866-01F343DBBA0FQ36368186-40AC800A-2B3D-4B56-AC6F-B99A95D9F7BCQ36421035-9951491D-3F2D-46AE-AFAF-BCFAECD5CB59Q36908396-7361E51B-42EB-4795-BAFB-04295C996321Q37310574-EDC9472C-9DF9-4CFB-B76F-9672E4F1D3D0Q37551949-A170B97B-F048-4A8A-91A6-D88B0C0265ADQ38147318-3DAC4C5E-2B00-4F70-BD27-A08F02CE119C
P2860
Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Identification of downstream-i ...... by full-length c-Myc proteins.
@ast
Identification of downstream-i ...... by full-length c-Myc proteins.
@en
type
label
Identification of downstream-i ...... by full-length c-Myc proteins.
@ast
Identification of downstream-i ...... by full-length c-Myc proteins.
@en
prefLabel
Identification of downstream-i ...... by full-length c-Myc proteins.
@ast
Identification of downstream-i ...... by full-length c-Myc proteins.
@en
P2093
P2860
P356
P1476
Identification of downstream-i ...... by full-length c-Myc proteins.
@en
P2093
P2860
P304
P356
10.1128/MCB.17.3.1459
P407
P577
1997-03-01T00:00:00Z